医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

BIT Group Establishes IVD-Focused Contract Manufacturing Facility in China

2015年10月29日 PM04:00
このエントリーをはてなブックマークに追加


 

SCHWALBACH, Germany

BIT Group has revealed the establishment of a second Chinese manufacturing operation in Shenzhen, China as a joint venture with EDAN Instruments, Inc., a Shenzhen-based leader in medical monitoring technology. The additional capacity and capabilities provided by the newest facility will enable BIT to provide comprehensive IVD manufacturing capabilities and third-party Contract Manufacturing Services (CMS).

“The Chinese medical technology market is expected to grow at double digit rates in the coming years,” explains Marius Balger, BIT CEO. “Our newest China facility will allow us to provide our clients with an outsourced CMS alternative to those which are not focused on the IVD business and lack experience with system development and system contract manufacturing.”

BIT specializes in contract product development, manufacturing and after-sales services for life science, medical and IVD instrumentation OEMs; EDAN is an established company in the medical monitoring business. By joining forces, both partners remain focused on core competencies, while providing a dedicated IVD contract manufacturing solution for OEM’s seeking entry to the China market or for local OEM’s requiring a transnational company to bridge local domestic needs.

BIT’s global clients will benefit from the new ISO1385-certified facility through competitive product pricing as well as Chinese domestic supply of product, lower transport and import costs, and an expedited regulatory approvals process within the Chinese market. BIT will offer CMS IVD solutions from this new facility to its clients globally.

BIT Group provides contract product development, manufacturing and after-sales services, as well as white-label instruments, for life science, medical and IVD instrumentation OEMs. Quality standards include GMP, FDA registered, ISO13485 & 9001, QSR, Class I, II, and III. BIT Group’s global operations in USA, Germany, France, China & Japan deliver precision engineered, cost effective systems solutions. Pre-engineered BIT SMARTSOLUTIONS™ platform technologies reduce development cost and time-to-market; lean manufacturing centers and global supply chain enable competitive product cost.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151029005264/en/

CONTACT

BIT Group
Jari Palander, +1-949-238-1277
Executive VP
J.Palander@BIT-Group.com
www.BIT-Group.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent